Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.7 0 (0%) Market Cap: 2.45 Bil Enterprise Value: 4.93 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 62/100

Amneal Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 15, 2020 / 08:15PM GMT
Release Date Price: €3.33 (+8.50%)
David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst

Good afternoon, everyone, and thank you for joining us. My name is Dave Risinger, and I'm responsible for U.S. pharmaceuticals at Morgan Stanley, including both major and specialty pharmaceuticals. And it's very much my pleasure to welcome the senior leaders of Amneal to join us for the conversation.

I do need to refer you to the disclaimer at www.morganstanley.com\researchdisclosures. And if you're a member of the press, we ask you to disconnect and reach out to Morgan Stanley public relations.

So with us today, we have both Chirag Patel and also Chintu Patel who are the original co-Founders and co-CEOs of the company. They originally founded Amneal in 2002. And they returned last summer, in the summer of 2019 as co-CEOs. They also brought in Tasos Konidaris who is the company's CFO. So we're pleased to have Tasos with us as well.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot